Find a Commonwealth Resource
Bexagliflozin
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Brenzavvy (bexagliflozin) is a prescription oral tablet used to manage type 2 diabetes by lowering blood sugar levels. As an SGLT2 inhibitor, it helps the kidneys remove excess glucose through urine. Available in 20 mg strength, manufactured by TheracosBio, LLC. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Bexagliflozin
Access the FDA dataset for Bexagliflozin — ANDA 203308 submitted by Mylan Institutional LLC
Modified Mar 24, 2026